Feasibility of telehealth interventions in care-transition.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Capacity to give informed consent, able to participate in the intervention and consent to participate in the TicTac-HF study - Patients with decompensated heart failure and preserved ejection fraction (HFpEF) - All NYHA classes I–IV - Ownership of an internet-enabled mobile phone, tablet, or PC (with video capability) - German-speaking - Discharge to home
Exclusion criteria
Exclusion criteria: - Lack of capacity to give informed consent, unable to participate in the intervention or no consent to the TicTac-HF study - No index hospitalization as defined in the “inclusion criteria” (no admission due to decompensation of HFpEF) - Requires mechanical ventilation due to cardiogenic shock or similar - < 18 years of age - HFmrEF or HFrEF patients - Does not own an internet-enabled mobile phone, tablet, or PC (or lacks video functionality) - Non-German speaker - Failure to participate in the mandatory video consultation - Discharges to specific care settings (e.g. nursing home, long-term care) - Planned, elective inpatient stays up to 30 days post-discharge - Existing pregnancy - Kidney disease requiring dialysis - Death during the index hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome is the feasibility of telehealth interventions in care-transition for adult patients with chronic heart failure in Germany. Among other things, feasibility is operationalised by examining the recruitment rate, the proportion of declined participation, the proportion of patients who received the telehealth intervention in full and the proportion of patients who generally meet the inclusion criteria. It is also assessed by gauging acceptance of the telehealth intervention among patients and HCP. This acceptance is assessed using structured questionnaires (e.g. the Telehealth Usability Questionnaire (TUQ)). | — |
Secondary
| Measure | Time frame |
|---|---|
| The study will examine clinical (e.g. quality of life), treatment-related (e.g. number and discrepancies in medication sources 30 days after discharge), intervention-specific (e.g. app usage) and patient-centered (e.g. health literacy) endpoints as secondy outcomes. | — |
Countries
Germany
Contacts
Innere Medizin IX, Abteilung für Klinische Pharmakologie und Pharmakoepidemiologie, Kooperationseinheit Klinische Pharmazie